Describe the fluoroquinolones with their classification, uses and adverse effects.
Mechanism and Classification
Fluoroquinolones inhibit bacterial DNA gyrase (topoisomerase II) in gram-negative organisms and topoisomerase IV in gram-positive organisms, preventing DNA supercoiling and replication. They are bactericidal and concentration-dependent.
| Generation | Drugs | Spectrum |
|---|---|---|
| First | Nalidixic acid | Gram-negative urinary organisms only; obsolete |
| Second | Ciprofloxacin, ofloxacin, norfloxacin | Broad gram-negative including pseudomonas; limited gram-positive; ciprofloxacin is the most active against Pseudomonas |
| Third | Levofloxacin | Added gram-positive and atypical cover — "respiratory quinolone" |
| Fourth | Moxifloxacin, gatifloxacin | Best gram-positive, atypical and anaerobic cover; moxifloxacin is not excreted renally, so it is unsuitable for urinary infection |
Uses
- Urinary tract infection, including complicated and pyelonephritis — though resistance is now high in India
- Typhoid — formerly first-line, but resistance is now widespread in South Asia and azithromycin or ceftriaxone is generally preferred
- Bacterial gastroenteritis — Shigella, Campylobacter, travellers diarrhoea
- Respiratory — levofloxacin and moxifloxacin for community-acquired pneumonia and exacerbations of chronic bronchitis
- Pseudomonas infections, including malignant otitis externa; ciprofloxacin is one of few oral options
- Bone and joint infection, prostatitis (good penetration), gonorrhoea (where sensitive)
- Meningococcal prophylaxis (single-dose ciprofloxacin); anthrax
- Second-line antitubercular — levofloxacin and moxifloxacin are central to multidrug-resistant tuberculosis regimens
CLINICAL PEARL
Using a fluoroquinolone for a trivial infection can compromise tuberculosis treatment. These drugs are backbone agents in multidrug-resistant tuberculosis, and casual use selects resistance in an undiagnosed patient. Worse, giving one for an undiagnosed fever partially treats tuberculosis, producing temporary improvement that delays diagnosis. In India, where the burden is high, this is a specific and serious argument for restraint.
Adverse Effects
- Tendinitis and tendon rupture, classically the Achilles tendon; risk increased by age over 60, corticosteroids and renal impairment; may occur weeks after the course
- Arthropathy in immature animals, which led to their traditional avoidance in children and pregnancy; the human evidence is weaker, and they are used where the benefit is clear
- CNS — headache, dizziness, insomnia, confusion; lower the seizure threshold, particularly with NSAIDs; psychosis in the elderly
- QT prolongation and torsades, greatest with moxifloxacin
- Peripheral neuropathy, sometimes irreversible
- Aortic aneurysm and dissection — a recognised association, so they are avoided in those at risk
- Gastrointestinal upset; Clostridioides difficile colitis; photosensitivity; dysglycaemia (gatifloxacin was withdrawn for this)
Interactions and Practical Points
- Chelation — antacids, calcium, iron, zinc, magnesium, sucralfate and dairy products prevent absorption almost completely; doses must be separated by at least 2 hours. This is a very common and entirely avoidable cause of treatment failure
- Ciprofloxacin inhibits CYP1A2 and raises theophylline and caffeine levels, risking seizures and arrhythmia
- Increases warfarin effect; monitor the INR
- With NSAIDs, the seizure risk rises
- Excellent oral bioavailability, close to intravenous — so oral treatment is appropriate even in fairly sick patients, which saves cost and lines
Applied Aspects
- Regulatory agencies now advise against fluoroquinolones for uncomplicated infections — simple cystitis, sinusitis, bronchitis — where safer alternatives exist, because of the disabling and sometimes permanent musculoskeletal and neurological effects
- Resistance in India is very high for E. Coli, Salmonella typhi and Shigella, largely from unrestricted use; local antibiograms should guide empirical choice rather than textbook spectra
- Warn patients to stop the drug and seek advice for tendon pain, and avoid strenuous exercise during and shortly after treatment
- Avoid in epilepsy, myasthenia gravis and known QT prolongation
- Never give with milk, antacids or iron, and say so explicitly — patients naturally take tablets with milk
All questions in Antimicrobials: General & Antibacterials
- Q1Describe the general principles of antimicrobial therapy including selective toxicity, classification, pharmacodynamic patterns and combination therapy. ★
- Q2Classify penicillins. Describe their mechanism of action, pharmacokinetics, uses and adverse effects. ★
- Q3Classify cephalosporins by generation. Describe the other beta-lactams and their uses and adverse effects. ★
- Q4Describe the aminoglycosides and macrolides with their mechanisms, uses and toxicity. ★
- Q5Describe the mechanisms of antimicrobial resistance, its spread and the principles of antimicrobial stewardship. ★
- SN1Describe the fluoroquinolones with their classification, uses and adverse effects. ★
- SN2Describe the tetracyclines and chloramphenicol with their uses and adverse effects. ★
- SN3Describe the sulphonamides and trimethoprim. Explain the basis of their synergy and the uses of co-trimoxazole. ★
- SN4Describe vancomycin and the other drugs used against MRSA and resistant gram-positive organisms. ★
- SN5Define chemoprophylaxis. Describe the principles of surgical and medical antimicrobial prophylaxis. ★
- SN6Define superinfection. Describe Clostridioides difficile colitis and its management. ★
- SN7Classify antiseptics and disinfectants. Describe the important agents and the factors affecting their activity.